Wednesday, July 8, 2026

biotech · Non-muscle Invasive Bladder Cancer · Intestinal Failure · TARA

Protara Therapeutics

Protara Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

New York, USA HQ
2017 Founded
56 Employees
Public company Type
TARA · NYSE Ticker
Company details
Status
Public
HQ
New York, USA
Founded
2017
Employees
56
Programs
7
Drugs
10
Patents
2
Intelligence · Clinical Programs

Protara Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Protara Therapeutics.

Protara Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Subcutaneous depot medroxyprogesterone acetate

    Protara Therapeutics

    Contraception

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Protara Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.